Tech & InnovationAnthropic is bringing its AI into small business tools like QuickBooks and PayPalUpdated May 13, 2026
Tech & InnovationSam Altman says Elon Musk sought total control of OpenAI from the startUpdated May 13, 2026
Tech & InnovationA space startup is teaming with a pharma company to manufacture lung disease drugs in orbitUpdated May 13, 2026
Tech & InnovationSAP is embedding Nvidia's security runtime into its AI platform for enterprise agentsUpdated May 13, 2026
Tech & InnovationA judge is making Elon Musk and the SEC defend their Twitter settlementUpdated May 13, 2026
Business NewsWendy's is offering free limited-edition merch drops to loyalty members for 4 weeksUpdated May 13, 2026
Money & MarketsSoftBank's Vision Fund surged $46 billion last year. OpenAI powered almost all of itUpdated May 13, 2026
Money & MarketsNvidia helps push stock futures higher as Jensen Huang joins Trump's trip to ChinaUpdated May 13, 2026
Tech & InnovationAlibaba's profit almost vanished even as cloud revenue surged on AI demandUpdated May 13, 2026
Money & MarketsMillions of student loan borrowers fell into default in early 2026, New York Fed findsUpdated May 12, 2026
Business NewsU.S. has cleared $35.5 billion in illegal tariff refunds for importersUpdated June 3, 2026
Business NewsSenate confirmed Kevin Warsh as a Fed governor, setting up a separate chair voteUpdated May 12, 2026
Business NewsAlphabet's Isomorphic Labs raised $2.1 billion to push AI-designed drugs toward clinical trialsUpdated May 12, 2026
Tech & InnovationAnthropic's Mythos AI is sending U.S. banks rushing to patch thousands of security holesUpdated May 12, 2026
Tech & InnovationCanvas owner struck a deal with hackers who breached its education platform twiceUpdated May 12, 2026
Business NewsCrumbl's founders are stepping down as the dessert chain searches for outside leadershipUpdated May 12, 2026
Business NewsPepsiCo's Bubly is bringing back its fan-favorite ice pop sparkling water nationwideUpdated May 12, 2026
Business NewsBristol Myers Squibb is striking a $15 billion drug licensing deal with China's Hengrui PharmaUpdated May 12, 2026